Ascentage Pharma Group International ADR - W/I
AAPGV17.3800.00% ( 0.000 )
Q2 FY2024 Earnings
Financial report interval: 2024.03.30 - 2024.06.30
Overview: Ascentage Pharma Group International ADR - W/I(AAPGV) the Revenue is 56.67 M (+477.4%);the EPS is 0.0378 (+137.4%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.06B477.37%
----
----
EPS
0.0378137.42%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf